Esperion files new drug submissions in Canada for Nexletol and Nexlizet as a treatment for reducing bad cholesterol and ...
The body needs some cholesterol to maintain good health. But for those who need to reduce the risk of a heart attack or stroke, statin drugs lower ... analysis in the New England Journal of ...
Esperion (ESPR) has filed New Drug Submissions to Health Canada for NEXLETOL and NEXLIZET, once-daily, accessible, oral non-statin medications ...
A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as ...
Esperion shares were up 13% to $3.16 after the company said it has filed New Drug Submissions to Health Canada for Nexletol and Nexlizet, non-statin medications that reduce low-density lipoprotein ...
If you have high cholesterol, your doctor may prescribe you with a type of statin. Here’s what you need to know. Statins are a group of medications used to treat high cholesterol. They work by ...
A new study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as the ...
a class of drug that effectively reduces cholesterol. Guidelines for doctors do not recommend prescribing statins to diabetic patients unless they have high cholesterol levels. But the new ...
Overall, a 20% decrease in LDL cholesterol was seen. Participants reported that they would have found more information on drug interactions ... make statins unavailable to non-insured or indigent ...
A UCLA study has outlined a new framework that researchers say would improve the predictive power of genetics to determine ...
The patient asked: "I have high cholesterol, but when I tried statins, I didn't like the side effects. What are non-pharmaceutical ways ... to the impact of older statin drugs from the '90s.
has submitted New Drug Submissions to Health Canada for two cholesterol-lowering medications, NEXLETOL and NEXLIZET, the company announced today. These oral, non-statin drugs are designed to ...